HHS is seeking information on how to make the healthcare system more patient-centric by, among other things, encouraging consumer choice in selecting insurance plans.
A federal judge has ordered the state of Illinois to pay $286 million more toward Medicaid bills every month and an additional $1 billion during the next year.
The Food and Drug Administration took steps Tuesday to try to curb drug prices by increasing competition in the pharmaceutical market. The agency published a list of off-patent branded drugs without approved generics and will expedite review of generic drugs that have few competitors.
A federal appeals court ruled Monday that the U.S. Drug Enforcement Agency does not need a court order to subpoena a prescription drug database kept by the state of Oregon. The ruling did not specify whether those subpoenas would violate constitutional protections.
The co-owner of a compounding pharmacy deemed responsible for the deaths of 76 people in a national meningitis outbreak tearfully apologized to the victims on Monday and was sentenced to nine years in prison, far less than the victims had wanted.
The Senate Republican draft bill bombed with healthcare providers, while some insurers reveled at the offering of cost-sharing reduction payments and tens of billions in temporary reinsurance funding.
The Federal Trade Commission and North Dakota’s attorney general challenged Sanford Health's proposed acquisition of the physician group Mid Dakota Clinic, alleging the combined group would have at least a 75% share of the physician primary-care market in Bismarck, N.D.
The Senate's proposed bill to replace Obamacare was immediately met with widespread dissent from members of both parties in Congress, healthcare providers, some insurers and perhaps most vehemently, patient advocacy groups. Here are the thoughts, opinions and comments made on the BCRA.
Prosecutors say the co-founder of a Massachusetts pharmacy linked to a deadly nationwide meningitis outbreak should be sent to prison for 35 years for showing "an unconscionable disregard for the lives of the patients."
The Senate's proposed bill to replace Obamacare was immediately met with widespread dissent from healthcare providers throughout the country, including one of the largest for-profits, Tenet Healthcare.
Business likes certainty, and that's doubly true for the insurance industry. The lack of legislation this far into the year has been particularly harmful to carriers, which must make decisions now about 2018 rates.
On Tuesday the White House will defend proposed cuts to the FDA budget that physicians fear will mean lax oversight of drug approval.